Coty Inc. (COTY) Drops 21% Amid Another Retailer Inventory Destocking Disclosure — Hagens Berman

(NYSE:COTY), SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) — On August 21, 2025, investors in Coty Inc. (NYSE: COTY) saw the price of their shares fall $1.05 (-21%) after the company reported its FY 2025 and Q4 financial results and revealed ongoing inventory destocking issues. The company's earnings disclosures have prompted national shareholders rights firm […]

Hua Hin Real Estate Market Set for Strong Growth, Says Location Real Estate

Hua Hin, Thailand, Sept. 02, 2025 (GLOBE NEWSWIRE) — Location Real Estate, an independent Hua Hin property agency founded by long-time resident Jon Martin, has shared insights into the Hua Hin real estate market for 2025 and beyond. With demand growing among retirees, investors, and international buyers, the outlook highlights promising opportunities across established neighborhoods,

Sparton Annual General Meeting Elects Two New Strategic Directors Bringing New Expertise to the Board

(TSX-V:SRI), TORONTO, Sept. 02, 2025 (GLOBE NEWSWIRE) — Sparton Resources Inc. (TSXV-SRI) (“Sparton” or the “Company“) announced today that its Annual General Meeting, held Wednesday, August 6, 2025, resulted in the election of two new members to the Board of Directors with over 99% of the votes cast approving their election. The new members bring

CENTRESTAGE ELITES unveils Guo Pei's Hong Kong solo couture debut, Star-studded runway show highlights 30+ unique creations

Organised by the Hong Kong Trade Development Council (HKTDC) and sponsored by the Cultural and Creative Industries Development Agency (CCIDA) of the Government of the Hong Kong Special Administrative Region (HKSAR), CENTRESTAGE – the annual gala event for the Asian fashion industry ' takes place from 3 to 6 September 2025 at the Hong Kong

Hua Hin Real Estate Market Set for Strong Growth, Says Location Real Estate

Hua Hin Real Estate Market Set for Strong Growth, Says Location Real Estate International demand for houses, condos, and luxury properties continues to rise in Hua Hin, with new off plan projects creating opportunities for global buyers. GlobeNewswire September 02, 2025 Hua Hin, Thailand, Sept. 02, 2025 (GLOBE NEWSWIRE) — Location Real Estate, an independent

Sparton Annual General Meeting Elects Two New Strategic Directors Bringing New Expertise to the Board

Sparton Annual General Meeting Elects Two New Strategic Directors Bringing New Expertise to the Board GlobeNewswire September 02, 2025 TORONTO, Sept. 02, 2025 (GLOBE NEWSWIRE) — Sparton Resources Inc. (TSXV-SRI) (“Sparton” or the “Company“) announced today that its Annual General Meeting, held Wednesday, August 6, 2025, resulted in the election of two new members to

Piedmont Heart Institute Performs Record Number of Heart Transplants

Piedmont Heart Institute set a new organizational record in 2024 by performing 103 heart transplants at Piedmont Atlanta Hospital. Since starting in 2012, the heart transplant program has performed more than 375 heart transplants. https://mma.prnewswire.com/media/2592705/Piedmont_Healthcare_Logo.jpg Piedmont performs more heart transplants than most transplant centers in the country; only three do more. In addition to being

SOHM, Inc., Moving and Expanding Commercialization Capabilities with its New Vista, CA Facility

CHINO HILLS, CA / ACCESS Newswire / September 2, 2025 / SOHM, Inc. (OTCID:SHMN), a leading pharmaceutical company developing next-generation gene editing solutions, today announced the relocation of its operations to a newly outfitted commercialization facility at 1396 Poinsettia Avenue, Vista, California. SOHM will have ample specialized space within the 24,000 square-foot industrial building, which

Evommune Announces Late-Breaker Presentation of Phase 2 Data for EVO756 in Chronic Inducible Urticaria at Upcoming European Academy of Dermatology and Venereology (EADV) 2025 Congress

Company to host a webcast to review the full data set from Phase 2 trial — Evommune, Inc., a clinical stage biotechnology company discovering and developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced that a full data setfrom the Phase 2 trial of EVO756 in adults with chronic inducible urticaria

Scroll to Top